[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2031462T3 - Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. - Google Patents

Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.

Info

Publication number
ES2031462T3
ES2031462T3 ES198787104071T ES87104071T ES2031462T3 ES 2031462 T3 ES2031462 T3 ES 2031462T3 ES 198787104071 T ES198787104071 T ES 198787104071T ES 87104071 T ES87104071 T ES 87104071T ES 2031462 T3 ES2031462 T3 ES 2031462T3
Authority
ES
Spain
Prior art keywords
arabinofuranosilcitosina
produce
procedure
sterarilfosfato
monosodico
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787104071T
Other languages
English (en)
Inventor
Takashi Terada
Minoru Aoki
Hiroshi Ohtaki
Manami Morozumi
Mitsuharu Shiozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Yamasa Shoyu KK
Original Assignee
Nippon Kayaku Co Ltd
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61063963A external-priority patent/JPS62221696A/ja
Priority claimed from JP61114680A external-priority patent/JPS62273993A/ja
Application filed by Nippon Kayaku Co Ltd, Yamasa Shoyu KK filed Critical Nippon Kayaku Co Ltd
Application granted granted Critical
Publication of ES2031462T3 publication Critical patent/ES2031462T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UN NUEVO PROCEDIMIENTO PARA PRODUCIR LA SAL MONOSODICA DEL 1-BETA-D-ARABINOFURANOSILCITOSINA-5''-ESTEARILFOSFATO, QUE SE ANUNCIA COMO AGENTE ANTITUMORAL Y DE SU MONOHIDRATO A PARTIR DE DICHA SAL MONOSODICA. TAMBIEN SE DESCRIBE UNA COMPOSICION FARMACEUTICA QUE CONTIENE EL MENCIONADO MONOHIDRATO Y SU EMPLEO COMO MEDICAMENTO, EN ESPECIAL EN EL TRATAMIENTO DE TUMORES.
ES198787104071T 1986-03-24 1987-03-19 Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. Expired - Lifetime ES2031462T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61063963A JPS62221696A (ja) 1986-03-24 1986-03-24 1−β−D−アラビノフラノシルシトシン−5′−ステアリルりん酸モノナトリウム塩・1水和物
JP61114680A JPS62273993A (ja) 1986-05-21 1986-05-21 1−β−D−アラビノフラノシルシトシン−5′−ステアリルりん酸ナトリウム塩の新規製造法

Publications (1)

Publication Number Publication Date
ES2031462T3 true ES2031462T3 (es) 1992-12-16

Family

ID=26405089

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787104071T Expired - Lifetime ES2031462T3 (es) 1986-03-24 1987-03-19 Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.

Country Status (8)

Country Link
US (2) US4812560A (es)
EP (1) EP0239015B1 (es)
KR (1) KR910008801B1 (es)
AU (1) AU592165B2 (es)
CA (1) CA1270820A (es)
DE (1) DE3773716D1 (es)
ES (1) ES2031462T3 (es)
HU (1) HU196429B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3773716D1 (de) * 1986-03-24 1991-11-21 Nippon Kayaku Kk Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
ES2160582T3 (es) * 1992-04-03 2001-11-16 Nippon Kayaku Kk Capsula dura de ocfosfato de citarabina.
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
WO2003057217A1 (en) 2002-01-14 2003-07-17 Novartis Ag Combinations comprising epothilones and anti-metabolites
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5516440B2 (es) * 1973-11-08 1980-05-01
JPS5289681A (en) * 1976-01-22 1977-07-27 Yamasa Shoyu Co Ltd Preparation of aracytidine -5# phosphoric acid ester derivatives
JPS552601A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd Anti-tumor agent for non-injection use
JPS55129299A (en) * 1980-03-14 1980-10-06 Yamasa Shoyu Co Ltd 1-beta-d-arabinofuranosyl-cytosine-5'-phosphoric alkyl ester
DE3773716D1 (de) * 1986-03-24 1991-11-21 Nippon Kayaku Kk Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
JP3236058B2 (ja) * 1992-04-14 2001-12-04 富士通テン株式会社 オーディオ再生装置

Also Published As

Publication number Publication date
US4812560A (en) 1989-03-14
EP0239015A2 (en) 1987-09-30
KR910008801B1 (ko) 1991-10-21
KR870008909A (ko) 1987-10-22
CA1270820A (en) 1990-06-26
HU196429B (en) 1988-11-28
HUT44270A (en) 1988-02-29
EP0239015B1 (en) 1991-10-16
US5049663A (en) 1991-09-17
AU592165B2 (en) 1990-01-04
DE3773716D1 (de) 1991-11-21
AU7047587A (en) 1987-10-01
EP0239015A3 (en) 1989-03-22

Similar Documents

Publication Publication Date Title
AU7023987A (en) Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
MY125414A (en) Aminopropylphosphinic acids
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
AR001073A1 (es) Benzoilguanidinas basicamente sustituidas procedimientos para su preparación su empleo como medicamento o agente de diagnostico asi como medicamento que las contiene
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
MX9400038A (es) Composiciones y metodos para proveer un efecto analgesico mejorado.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 239015

Country of ref document: ES